WHO Guidelines & GMP Standards
Sterile Medicinal Products GMP: Contamination Control Strategy (CCS) & Aseptic Isolator Standards
Regulatory inspection benchmark for sterile parenteral facilities (HS Code 3004.90) enforcing holistic Contamination Control Strategies (CCS) across Grade A–D cleanroom zones. Facilities utilizing Restricted Access Barrier Systems (RABS) or closed isolators must validate automated Vaporized Hydrogen Peroxide (VHP) bio-decontamination cycles.
- Environmental Monitoring: Continuous non-viable particulate counting (≥0.5 μm and ≥5.0 μm) in Grade A filling zones; zero CFU tolerance on settle plates and contact plates during aseptic processing.
- Container Closure Integrity: 100% deterministic Container Closure Integrity Testing (CCIT) such as High-Voltage Leak Detection (HVLD) or vacuum decay for fusion-sealed ampoules and vials.
Official Source & Verification Reference
Issuing Authority: World Health Organization (WHO) Prequalification & GMP Unit • Reference: WHO-GMP-STERILE-2026
Verify Official Source Document ↗